Literature DB >> 32305424

Intra-Articular Injections of Hyaluronic Acid or Steroids Associated With Better Outcomes Than Platelet-Rich Plasma, Adipose Mesenchymal Stromal Cells, or Placebo in Knee Osteoarthritis: A Network Meta-analysis.

Seung-Beom Han1, In-Wook Seo2, Young-Soo Shin3.   

Abstract

PURPOSE: To evaluate the clinical effects of hyaluronic acid (HA), steroids, platelet-rich plasma (PRP), or adipose mesenchymal stromal cell (MSC) injections in the treatment of knee osteoarthritis (OA).
METHODS: Randomized controlled trials with OA of the knee that compared HA, steroids, PRP, adipose MSC, or their combination with placebo or in head-to-head combination were identified from the MEDLINE, EMBASE, Cochrane Library, Web of Science, and SCOPUS databases up to June 30, 2019. We performed a network meta-analysis of the relevant literature to determine whether there was benefit from HA, steroids, PRP, or adipose MSC treatment as compared with placebo.
RESULTS: A total of 43 trials covering 5554 patients were included. Steroids were ranked most likely to be effective for the management of pain or function, with adipose MSC and multiple PRP appearing least likely to be effective. Although no significant difference was observed among the 6 interventions, except for single PRP with respect to adverse effects, steroids and HA exhibited a lower rate of AEs compared with the placebo. In view of severe adverse effects, only single PRP was superior to placebo. Direct pairwise meta-analysis for pain relief showed that HA was superior to placebo or single PRP, but steroids had a significantly worse effect than single PRP. In addition, direct pairwise meta-analysis for adverse effects favored steroids in comparison to HA.
CONCLUSIONS: The ranking statistics like surface under the cumulative ranking curve values of our network meta-analysis support the use of steroids and HA for appropriate patients with knee OA. For pain relief and AEs, steroids are most likely the best treatment, followed by HA. Single PRP, multiple PRP, and adipose MSC interventions do not result in a relevant reduction of joint pain nor improvement of joint function compared with placebo. However, treatment effect differences were small and potentially not clinically meaningful, indicating that other factors, such as cost and patient preferences, may be more important in patients with knee OA. LEVEL OF EVIDENCE: meta-analysis of non-homogenous randomized controlled trials, Level II.
Copyright © 2020 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32305424     DOI: 10.1016/j.arthro.2020.03.041

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  12 in total

Review 1.  Stem cell-based therapy for human diseases.

Authors:  Duc M Hoang; Phuong T Pham; Trung Q Bach; Anh T L Ngo; Quyen T Nguyen; Trang T K Phan; Giang H Nguyen; Phuong T T Le; Van T Hoang; Nicholas R Forsyth; Michael Heke; Liem Thanh Nguyen
Journal:  Signal Transduct Target Ther       Date:  2022-08-06

Review 2.  Mesenchymal Stem Cell Mechanisms of Action and Clinical Effects in Osteoarthritis: A Narrative Review.

Authors:  Vilim Molnar; Eduard Pavelić; Kristijan Vrdoljak; Martin Čemerin; Emil Klarić; Vid Matišić; Roko Bjelica; Petar Brlek; Ivana Kovačić; Carlo Tremolada; Dragan Primorac
Journal:  Genes (Basel)       Date:  2022-05-26       Impact factor: 4.141

3.  Intra-Articular Injection of Platelet-Rich Plasma Is More Effective than Hyaluronic Acid or Steroid Injection in the Treatment of Mild to Moderate Knee Osteoarthritis: A Prospective, Randomized, Triple-Parallel Clinical Trial.

Authors:  Dawid Szwedowski; Ali Mobasheri; Andrzej Moniuszko; Jan Zabrzyński; Sławomir Jeka
Journal:  Biomedicines       Date:  2022-04-25

4.  Effects of platelet-rich plasma injection for pain control and cartilage repair in knee osteoarthritis: A protocol for the systematic review and meta-analysis of randomized controlled trials in animal models.

Authors:  Li Bocun; Li Jing; Li Jia; Qian Tan; Jianyi Chen; Zhongsheng Huang; Cai Guowei
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

5.  Treatment Efficacy with a Novel Hyaluronic Acid-Based Hydrogel for Osteoarthritis of the Knee.

Authors:  Octav Marius Russu; Tudor Sorin Pop; Andrei Marian Feier; Cristian Trâmbițaș; Zsuzsanna Incze-Bartha; Paul Gabriel Borodi; István Gergely; Sándor-György Zuh
Journal:  J Pers Med       Date:  2021-04-15

6.  Impact of the numbers of injections of platelet rich plasma on the clinical outcomes in patients with knee osteoarthritis: A protocol for an updated network meta-analysis.

Authors:  Pan Wang; Kai Li; Zuxin Jiang; Beiming Qiu; Cheng Nie; Hongsheng Luo; Zhengjiang Li
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

7.  Bone marrow aspirate concentrate versus platelet-rich plasma for treating knee osteoarthritis: a one-year non-randomized retrospective comparative study.

Authors:  Abed El-Hakim El-Kadiry; Carlos Lumbao; Natasha Salame; Moutih Rafei; Riam Shammaa
Journal:  BMC Musculoskelet Disord       Date:  2022-01-03       Impact factor: 2.362

8.  Circular RNA circ_0000423 regulates cartilage ECM synthesis via circ_0000423/miRNA-27b-3p/MMP-13 axis in osteoarthritis.

Authors:  Xing Li; Chaofan Xie; Fangjun Xiao; Haitao Su; Zhen Li; Jiaxian Weng; Yongming Huang; Peiheng He
Journal:  Aging (Albany NY)       Date:  2022-04-19       Impact factor: 5.682

Review 9.  A narrative review of the progress in the treatment of knee osteoarthritis.

Authors:  Zhijun Cai; Yi Cui; Jing Wang; Xin Qi; Pengju He; Pengfei Bu; Yongqing Xu; Yang Li
Journal:  Ann Transl Med       Date:  2022-03

Review 10.  Methodological Flaws in Meta-Analyses of Clinical Studies on the Management of Knee Osteoarthritis with Stem Cells: A Systematic Review.

Authors:  Christoph Schmitz; Christopher Alt; David A Pearce; John P Furia; Nicola Maffulli; Eckhard U Alt
Journal:  Cells       Date:  2022-03-11       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.